Active Ras-induced effects on skeletal myoblast differentiation and apoptosis are independent of constitutive

M Karasarides1, K Dee, D Schulman

  • 1Department of Cell Biology, Learner Research Institute, Cleveland Clinic Foundation, OH 44195, USA.

Insights

Constitutively active Ras mutants impair skeletal myoblast differentiation and apoptosis. A novel pathway, distinct from MAPK, NF-kappaB, or PI3-kinase, mediates these effects, offering new therapeutic targets.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Skeletal Muscle Research

Background:

  • Ras proteins are key regulators of cell signaling pathways.
  • Aberrant Ras signaling is implicated in various diseases, including cancer.
  • Understanding Ras function in skeletal myoblasts is crucial for muscle development and disease.

Purpose of the Study:

  • To investigate the cellular and molecular effects of different constitutively active H-Ras mutants in skeletal myoblasts.
  • To compare the signaling pathways activated by G12V:H-Ras and F156L:H-Ras.
  • To identify the signaling pathways responsible for impaired differentiation and apoptosis in Ras-expressing myoblasts.

Main Methods:

  • Establishment of 23A2 skeletal myoblast cell lines stably expressing G12V:H-Ras or F156L:H-Ras.
  • Assessment of cell morphology, differentiation, and apoptosis.
  • Analysis of signaling pathway activation (PI3-kinase, MAPK, NF-kappaB) and pharmacological inhibition studies.

Main Results:

  • G12V:H-Ras induced transformed morphology, abrogated differentiation and apoptosis, and activated PI3-kinase, MAPK, and NF-kappaB.
  • F156L:H-Ras did not induce transformed morphology but impaired differentiation and apoptosis without activating MAPK and NF-kappaB.
  • Constitutive PI3-kinase signaling was common to both mutants but not responsible for the observed differentiation/apoptosis defects.

Conclusions:

  • Constitutively active Ras proteins differentially affect skeletal myoblast phenotype and signaling.
  • A signaling pathway independent of MAPK, NF-kappaB, and PI3-kinase mediates the impaired differentiation and apoptosis.
  • This novel pathway represents a potential therapeutic target for conditions involving Ras dysregulation in skeletal muscle.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...